A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs.

Ruixiang LuoMengjun HuangYinghuai Wang

Published in: Evidence-based complementary and alternative medicine : eCAM (2021)

Ten genes of both high-and low-risk scores were associated with the prognosis of PC. PC prognosis may be related to immune disorders. SPOP, TP53, and TTN may be potential targets for the prognosis of PC.

Keyphrases

prostate cancer
transcription factor
radical prostatectomy
gene expression
genome wide
risk assessment
genome wide identification
dna binding
breast cancer risk